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Abstract
Objectives: To scrutinise claims about the effectiveness of the Standard Days Method® (SDM). The SDM is a calendar method with
similarities to the rhythm method that has now been reclassified and is marketed as a modern contraceptive method. As promoted, it requires
users to avoid unprotected intercourse on days 8–19 of the menstrual cycle. It is used in at least 100 countries. SDM has been researched,
developed, and is marketed by the Institute of Reproductive Health (IRH) at Georgetown University, USA, and a for-profit company Cycle
Technologies. SDM proponents say it is a major advance on traditional periodic abstinence, claiming that it is 95% effective when used
correctly — rivalling pills and condoms. The effectiveness claim is repeated in recent documents from the World Health Organization.
Study design: Evaluation of evidence obtained via literature review of published and unpublished reports.
Results: Claims made for SDM effectiveness appear to rely on a single efficacy study where “correct use" of SDM was defined as total
abstinence from intercourse in cycle days 8–19. It may therefore be misleading to apply a 95% effectiveness figure from the study to
SDM as promoted, where abstinence is not required. Moreover, “typical use” effectiveness figures, cited as 88%, are based on an
unrepresentative sample of women using SDM in ways likely to vary from how SDM is used in practice.
Conclusion: Existing evidence does not support claims that the effectiveness of SDM as promoted is comparable to the best short-acting
modern contraceptive methods. SDM is promoted in ways that may mislead users, by quoting overestimates of effectiveness and providing
efficacy comparisons only with selected methods of contraception. Users should be provided with full and accurate information to make
contraceptive choices.
Implications: Use, delivery and promotion of SDM should be reevaluated. Meanwhile, SDM should only be offered to family planning
clients as an adaptation of traditional periodic abstinence methods, requiring total abstinence in fertile days — reflecting “correct use" in the
efficacy study — to achieve high effectiveness. Delivery of any form of SDM should include presentation of the full range of other
contraceptive methods, including the most effective options.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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1. Introduction
The Standard Days Method® (SDM) is a calendar method
with similarities to the rhythm method that is marketed as a
modern contraceptive method. It is used in at least 100
predominantly low- and middle-income countries [1,13].
Claims for the method are eye catching: its proponents claim
95% effectiveness when used correctly [1,2], rivalling
better-known, short-acting contraceptives such as oral pills
or condoms [3], and representing “a major improvement"
over traditional periodic abstinence methods (p.13) [2].
Periodic abstinence is estimated to be between 76 and 83%
effective with typical use [4,5].
The SDM as promoted uses a proprietary CycleBeads®
necklace of coloured beads to help women track their
menstrual cycles, with white beads representing days to
avoid coitus or use back-up methods (Fig. 1). Women who
have cycles of 26 to 32 days use it by passing a rubber ring
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over one bead each day, with white beads representing
predicted fertile days 8–19 (12 days).1
The SDM has been researched, developed, promoted and
marketed through the Institute of Reproductive Health
(IRH) at Georgetown University, USA, and Cycle Tech-
nologies, a for-profit company, which sells CycleBeads®
and CycleBeads® Online (web-based application), and
produces iCycleBeads® and DOT™ (“Dynamic Optimal
Timing”) (mobile phone applications) [7–9]. SDM intro-
duction, scale up, and other activities have involved a wide
range of international organisations,2 largely funded by the
United States Agency for International Development
(USAID) [10,11]. The Bill and Melinda Gates Foundation
has also provided support for pilot efforts in two countries
[10].
Given that side effects are a major reason for contracep-
tive switching and discontinuation [5,12], the prospect of a
method with few or no side effects but— unlike most natural
methods — with high efficacy has obvious appeal for
programmers and clients. In settings where choice is limited
and good contraceptive counselling or support for switching
are nonexistent, stopping a method may mean stopping all
family planning. In such cases, a less effective method
requiring no follow-up may be preferable to no method at all.
The IRH promotes the Standard Days Method® as a
“modern” method of contraception [1,14,15]. The SDM is
now included in contraceptive guidance from the World
Health Organization (WHO), including Medical Eligibility
Criteria for Contraceptive Use [16]. The WHO recently
reclassified SDM as a modern method [17] following a
technical consultation on the classification of contraceptives,
jointly organised with USAID. We were not able to obtain
the consultation reports that might explain the rationale for
this change.
The new “modern” designation of SDM contrasts with the
“traditional” rhythm method. The term modern, rightly or
wrongly, [18] implies “effective” and indeed, strong claims
are made for SDM effectiveness, with the IRH and Cycle
Technologies making frequent references to the method
being over 95% effective and scientifically proven [1,2,19].
The IRH also promotes the method as simple to use and
claims that it improves partner communication [3,19]. The
SDM is proposed as a way to bring in new users of
contraception, and to overcome religious or cultural
concerns about family planning [3]. SDM may help users
adhere to Catholic doctrine on contraception, although many
countries where SDM is promoted, such as India, Mali or
Madagascar, are not predominantly Catholic, and popula-
tions in predominantly Catholic countries have long used
“artificial” methods.
The highest recorded national prevalence of SDM is low
(0.3% of 15–49 year old women reported current use in the
2010 Rwanda DHS [10]), although 15–20% of women using
family planning have been reported to use SDM in districts
in the Democratic Republic of Congo where the method has
been promoted [10,20,21].
The stakes are high: an ineffective family planning
method may increase recourse to abortion. For instance, one
15-country study showed periodic abstinence failure con-
tributed to one sixth of all foetal losses, most of which were
likely to be illegal induced abortions [4]. Abortion remains a
life-threatening procedure in many countries [22], including
countries where SDM is being promoted, and children born
from unwanted or unintended pregnancies may be at risk of
poorer outcomes than children born from planned pregnan-
cies [23].
The effectiveness claims made in SDM promotion have
not previously been independently scrutinised. This paper
provides a scientific review of the evidence so that family
planning programme managers, policy makers and contra-
ception users can make informed programming and method
choices.
2. Material and methods
Eight databases were searched in July 2015 including
Africa-wide Information, CINAHL Plus, EMBASE, Global
1 The period of peak ovulation probability was modelled using datasets
of menstrual cycles of women across the world, and the model suggested
the probability of conception on any given day outside the peak 8–19 day
time is 0.007 [6].
2 These include CARE, Catholic Relief Services, Centre for Develop-
ment and Population Activities (CEDPA), FHI360, JHPIEGO, Marie
Stopes International, Mercy Corps, PATH, Pathfinder, Population Council,
Population Reference Bureau, Population Services International, Project
Concern International, Save the Children, the United Nations Population
Fund (UNFPA), University Research Co., WHO, World Vision, and local
affiliates of the International Planned Parenthood Federation [10].
Fig. 1. Cyclebeads®.
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Health, International Bibliography of the Social Sciences,
MEDLINE, POPLINE, and Scopus. Databases were searched
using the terms standard days method and cyclebead*. In
addition, we searched the resource library at Georgetown
University's Institute for Reproductive Health [24], the Cycle
Technologies |Brilliantly Simple™ website [25] and the
WHO's Department of Reproductive Health and Research [26].
We reviewed titles and abstracts/executive summaries for
relevance and retained any that contained technical information
about SDM (e.g., effectiveness) or were promotional materials
about SDM. We categorised reports according to their main
themes and extracted summaries of key claims or findings into a
thematic matrix. We examined in detail the technical informa-
tion cited in support of SDM effectiveness claims.
3. Results
Our search yielded 137 unique items broadly covering the
topic of SDM, with 111 from IRH, USAID and collaborating
agencies. They covered research or implementation activities
in 25 countries across five continents. We found 34
peer-reviewed journal articles, 10 websites (including news
reports), and 93 other items including reports, summaries,
guidance on SDM use/implementation, commentaries, and
letters. One item was an online toolkit containing multiple
SDM educational and promotional materials. Eighteen
reports presented data on pregnancies during SDM use
(tally includes reviews containing duplicate data). For other
items, the primary themes were general information about
SDM (N=50), method development (N=7), acceptability and
use (N=29), and implementation (N=33).
One of the 18 reports with data on pregnancies was an
efficacy study of SDM use [6]. All the others were either
implementation studies, often with very small sample sizes,
and/or had designs that precluded robust effectiveness
calculations.
Claims about SDM effectiveness rely on the efficacy
study, published in this journal in 2002, by Arévalo et al.
among 478 women in Bolivia, Peru, and the Philippines [6].
In line with recommended practice [27] the Arévalo et al.
study analysed data from complete menstrual cycles from the
women, plus the first cycle where any pregnancy had
occurred, up to 13 months' worth per woman. Women who
became pregnant stopped contributing cycle data. Calcula-
tions of “correct use” (seemingly similar to perfect use i.e.
how effective methods can be, where perfect use is defined
as following the directions for use [28, p. 397]) used data
from the number of cycles contributed with and without
pregnancy. The study recorded 95% correct use effective-
ness where correct use was defined as “no intercourse on
days 8-19" p.336 [6].
The study recorded 88% effectiveness (i.e. 12% failure)
under what the authors describe as “typical use” conditions [6].
Typical use is generally defined as “how effective the different
methods are during actual use (including inconsistent or
incorrect use)” [28, p. 397]. While 12% failure may apply to
typical use within the study, the SDM study participants were
few in number (N=478), nonrandomly selected and atypical of
the general population (e.g., almost all had children, most were
literate) and so are subject to multiple biases and therefore not a
representative sample of the general population.Yet the IRHhas
criticised a suggestion to use a 24% typical use failure rate
estimate for SDM based on population rates for other fertility
awareness methods saying that its 12% figure should be quoted
[28–30].3
3.1. Accuracy of effectiveness claims
There are further problems with the estimates provided by
IRH, both in terms of the direct claim that SDM as promoted
is highly effective in preventing pregnancy and with the
implicit claim that SDM itself is a single, nonvarying entity.
A crucial point is that the SDM in theArévalo et al. study that
provides the figure of 95% effectiveness was different to SDM
as it is being promoted worldwide. The SDM as promoted
requires women to avoid unprotected intercourse, including
permitting the use of barrier methods, in days 8–19 of the cycle
[3]. Cycles contributing to the 95% effectiveness figure in the
study, on the other hand, involved participants abstaining
completely from coitus in those days. The authors explain that
cycles during which there was protected coitus on days 8–19
were excluded “because it is not possible to determine whether
the woman was protected from pregnancy by the SDM only or
by the other method" (p.335) [6]. The SDM as promoted,
however, does not rely solely on abstinence during days 8-19
and includes other methods.
When the 5% of efficacy study cycles that included use of
condoms and withdrawal (and so were excluded from
“correct use” figures) are included in the analysis, one year
SDM failure increased by around a fifth (5.7% vs. 4.8%
SDM failure with abstinence in days 8–19). This suggests an
effectiveness of SDM as promoted of less than the +95% that
has been claimed [1,19]— even when the promoted method
is used correctly — because substituting abstinence with
condoms or other methods inevitably raises the risk of
pregnancy.
Another key difference between the SDM in the study and
SDM as promoted is that women in the efficacy study were
required to use a paper calendar record of menstruation as
well as CycleBeads® [6]. Yet SDM as promoted does not
require a calendar. While a written calendar need only be
updated once per cycle (to record first day of menses),
CycleBeads® require women to remember to move the
rubber band along the beads each day and only once on each
day. Literate women with both beads and calendar can check
band position against the calendar. Yet CycleBeads® are
promoted using the high correct use effectiveness rates from
a study where calendars were used alongside them [13,19].
3 Publicity materials such as the front page of www.cyclebeads.com
prominently feature the figure of “95% effective”
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The efficacy of SDM in typical use is quoted as 88%
based on the efficacy study, yet the differences above
suggest typical use in the study may well be different to
typical use of the method as promoted. Moreover, Arévalo et
al. state that women's use of multiple record systems likely
improved the accurate tracking of days. They also point out
that the monthly follow-up for data collection may further
have increased correct use of the method [6].
All effectiveness figures were calculated based on cycles in
the range 26–32 days. Women were withdrawn from the study
if their cycles fell outside this range for two consecutive cycles.
The presence of twoormore cycles outside the 26–32-day range
is a contraindication for SDM [32], presumably because the
peak fertile days are more likely to fall outside cycle days 8–19
once cycles themselves are too short or long. In the efficacy
study, women were also excluded after a single N42 day cycle.
IRH guidance, however, also appears to suggest that women
may be deemed eligible without exact knowledge of cycle
length if their periods usually come “when expected” or “about a
month apart” [33].
“Out-of-range” cycles are common. Among study
participants, 28% had two consecutive out-of-range cycles
over the 13-month period and were withdrawn from the
study [6]. It appears that the out-of-range cycles contributed
by women before they were withdrawn are included in the
calculations of correct and typical use. However, there is a
danger that those ineligible women who start with an
in-range cycle length will continue to use the method, as
happened within the efficacy study, where “many" (p.338) of
the women withdrawn from the study after two out-of-range
cycles ignored advice to stop using SDM [6]. Presumably,
the effectiveness of the method is reduced when used by
women with out-of-range cycles.
3.2. Presentation of effectiveness claims
In IRH materials, SDM effectiveness is compared only
with that of selected short-acting methods. The materials we
found [3,31,32,34–37] — with one exception published by
USAID [38] — omit comparisons with any of the most
effective contraceptive methods, including injectables, the
intrauterine device, and implants.
The impression that scientific studies support 95%
effectiveness of SDM as promoted permeates most materials
on SDM, often without reference to typical use effectiveness.
For instance, the WHO advisory note on procurement of
CycleBeads®, which references the Arévalo et al. study,
states that, “[r]esearch has shown that SDM used with
CycleBeads® is more than 95% effective” [39]. The
CycleBeads® webpage states that, “[i]t's over 95% effective
as shown in efficacy trials (note the use of the plural
‘trials'— yet only one citation is provided on the website,
to Arévalo et al. [6]) and used by millions of women
around the world” [19].
The SDMwebsite [3] provides both 95% and 88% figures
but in large letters states: “When used correctly and
consistently — and most users do so — SDM is 95%
effective".
It may be difficult for users and providers to compare
SDM adequately with other methods because many sources,
including WHO guidance, present only the “correct use”
figure for SDM (95% effectiveness) with no typical use
effectiveness figures [1,2,39], even in places where other
methods are presented with their typical use effectiveness
figures [16,42].
4. Discussion
The SDM has been successfully promoted over the past
15 years, but the strong claims made for it do not stand up to
scrutiny. Effectiveness figures may mislead and seem
overoptimistic; promotional materials for SDM seem to put
the method in an artificially favourable light.
To assess SDM as promoted, additional trial data would
be needed to examine the effects of using methods other than
abstinence during days 8–19, as well as the effects of
guidance on estimating cycle length to determine eligibility
[33]. To understand use in situ, it would be helpful, too, to
investigate the extent to which use of CycleBeads® alone
leads to errors in cycle tracking compared with CycleBeads®
plus calendars. Overall typical use effectiveness should be
carefully investigated in a sample representative of the
general population.
It would also be useful to understand better the proportion
of users who manage to use SDM perfectly — which
requires them not only to avoid unprotected intercourse at
certain times, but also to keep track of their cycle length and
discontinue the method if they become ineligible. Trussell
notes the proportion of perfect users as one of four key pieces
of information that would help couples to make an informed
decision about their contraceptive method, saying: “The
percentage of perfect users or percentage of months during
which a method is used perfectly reveals how hard it is to use
a method correctly and consistently.” [28 p.397]. Perfect
use of SDM may also be easier or more difficult for some
groups — for instance those with access to a smartphone
app — and this deserves further investigation.
It is possible that promotion of SDM might help improve
knowledge and reduce failure rates for women using periodic
abstinence incorrectly. One study showed that only 62% of
self-reported periodic abstinence users in 15 DHS surveys
had a reasonably correct knowledge of the fertile period,
although the failure rate of those with correct knowledge was
only slightly better than among those women with incorrect
knowledge [4].
Users of short-acting methods already overestimate the
effectiveness of their method and underestimate the
effectiveness of long-acting methods [40]. Providing incor-
rect information in this context is therefore particularly
problematic, as well as working against the principle that
clients are entitled to correct information to help inform their
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health choices [41]. Some WHO family planning guidance
[16,42] quoting 5% failure rates for SDM defines the method
as requiring abstinence in days 8-19 of the cycle, however at
least two documents [17,39] appear to repeat the effective-
ness claims from IRH and the CycleBeads® manufacturer
without this qualification. In the absence of robust evidence
of the effectiveness of SDM as promoted, SDM should only
be offered to family planning clients with in-range cycles as
an adaptation of traditional periodic abstinence methods,
requiring total abstinence in fertile days and careful
monitoring of cycle length — reflecting “correct use" in
the efficacy study— to achieve high effectiveness. Delivery
of any form of SDM should include presentation of the full
range of other contraceptive methods, including the most
effective options.
Women and couples must receive full and accurate
information about the methods they use. Existing evidence
does not support claims that the effectiveness of SDM as
promoted is comparable to the best short-acting modern
methods. We therefore suggest that the use, delivery, and
promotion of the SDM should be reevaluated.
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